Loading...
Loading...
Contributors:
Dataset URI:
10.1371/journal.pmed.1004661.t003Survival, risk differences, and risk ratios at 5 years from baseline estimated in the observational emulation of a target trial comparing trastuzumab plus chemotherapy with chemotherapy, NKBC, and seven further Swedish registers, 2008–2015 (main analysis based on 1578 individuals).
Keyword(s):
578 women; 59 ]).; 59 years; 67 ]); aligning protocols.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)